glp 1 analogue brands GLP-1 Agonists Examples: Which One Wins? Targeting GLP-1, GIP & GCG

December [2025] was a rough month, let me tell you, the 46-year-old shared in a new interview, clarifying that she is good now.

By early 2025, nearly 25% of diabetes patients had started a GLP1 therapy, up from just 3% four years ago

Discover how Tirzepatide enhances insulin sensitivity, reduces blood sugar levels, and supports weight loss for better metabolic health in individuals with type 2 diabetes.

We published case reports and case series suggesting that these drugs may be beneficial for a large subset of patient population with #chronicillness.

RNA sequencing was utilized to analyse the underlying molecular mechanisms by which liraglutide affects fibroblast activation

Question: Is there an Ozempic pancreatitis lawsuit